Abstract
Purpose
The aim of this study was to determine how female age at the end of the reproductive spectrum effects success of natural cycle intrauterine insemination (IUI) or IUI in combination with ovarian stimulation.
Methods
We performed a retrospective cohort study of women 43 years of age and older at the time of IUI in a single academic fertility center between January 2011 and March 2018. Primary outcomes were both pregnancies and live births per cycle of IUI. Data are presented as percentage or mean ± SD. Fisher exact and chi-squared analyses were performed.
Results
There were 9334 IUI cycles conducted during the study period. Of these cycles, 325 IUIs (3.5%) were for women aged 43 years and over at the time of insemination (43.6 ± 0.8, range 43 to 47 years). Analysis of these 325 IUI cycles revealed 5 biochemical pregnancies (1.5%) and only 1 live birth (0.3%). The pregnancy rate did not differ between IUIs using donor sperm (N = 1/49, 2.0%) compared to IUIs with partner sperm (N = 4/276, 1.4%). The pregnancy rate did not differ between IUIs with gonadotropins (N = 2/211, 0.9%), clomiphene or letrozole (N = 2/78, 2.6%), or natural cycle (N = 1/36, 2.8%).
Conclusions
The use of intrauterine inseminations in women 43 years of age and older is an ineffective treatment strategy. This is irrespective of the use of ovarian stimulation or donor sperm. Costly gonadotropin injections did not increase the chance of pregnancy nor did oral medication when compared to natural cycle IUIs.
Similar content being viewed by others
References
Mathews TJ HB. Delayed childbearing: more women are having their first child later in life. NCHS data brief, no 21. p. 1–8. 2009.
ART Success Rates | CDC. [cited 2020 Apr 15]. Available from: https://www.cdc.gov/art/artdata/index.html
Milan A. Fertility: Fewer children, older moms. Stat Canada. 2014 [cited 2020 Apr 15];630–X. Available from: https://www150.statcan.gc.ca/n1/pub/11-630-x/11-630-x2014002-eng.htm
Khandwala YS, Zhang CA, Lu YEM. The age of fathers in the USA is rising: an analysis of 168 867 480 births from 1972 to 2015 - PubMed. Hum Reprod. 2017;32(10):2110–6.
Mathews TJ HB. First births to older women continue to rise - PubMed. NCHS Data Brief, p. 152:1–8. 2014. https//www.cdc.gov/nchs/products/databriefs.htm.
Provencher C, Milan A, Hallman S, Carol D. Fertility: overview, 2012 to 2016. Stat Canada. 2018. Available from: https://www150.statcan.gc.ca/n1/pub/91-209-x/2018001/article/54956-eng.htm
Maheshwari A, Porter M, Shetty A, Bhattacharya S. Women’s awareness and perceptions of delay in childbearing. Fertil Steril. 2008;90:1036–42.
Wyndham N, Marin Figueira PG, Patrizio P. A persistent misperception: assisted reproductive technology can reverse the “aged biological clock”. Fertil Steril. 2012;97:1044–7.
Mac Dougall K, Beyene YNR. Age shock: misperceptions of the impact of age on fertility before and after IVF in women who conceived after age 40. Hum Reprod. 2013;28:350–6.
Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. Oxford University Press. 1992;7:1342–6.
Haebe J, Martin J, Tekepety F, Tummon I, Shepherd K. Success of intrauterine insemination in women aged 40-42 years. Fertil Steril. 2002;78:29–33.
Belloc S, Cohen-Bacrie P, Benkhalifa M, Cohen-Bacrie M, de Mouzon J, Hazout A, et al. Effect of maternal and paternal age on pregnancy and miscarriage rates after intrauterine insemination. Reprod Biomed Online. Reproductive Healthcare Ltd. 2008;17:392–7.
Schorsch M, Gomez R, Hahn T, Hoelscher-Obermaier J, Seufert R, Skala C. Success rate of inseminations dependent on maternal age? An analysis of 4246 insemination cycles. Geburtshilfe Frauenheilkd. 2013;73:808–11.
Vichinsartvichai P, Siriphadung S, Traipak K, Promrungrueng P, Manolertthewan C, Ratchanon S. The influence of women age and successfulness of intrauterine insemination (IUI) cycles. J Med Assoc Thai. 2015 [cited 2020 Apr 16];98:833–8.
Practice Committee of the American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril. 2020;113(2):305–22.
Goldman MB, Thornton KL, Ryley D, et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertil Steril. 2014;101(6):1574–81.e812.
Schwartz D, Mayaux MJ. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. N Engl J Med. 1982;306:404–6.
Frederick JL, Denker MS, Rojas A, Horta I, Stone SC, Asch RH, et al. Infertility: is there a role for ovarian stimulation and intra-uterine insemination after age 40? Hum Reprod Oxford University Press. 1994;9:2284–6.
Legro RS, Shackleford DP, Moessner JM, Gnatuk CL, Dodson WC. ART in women 40 and over. Is the cost worth it? J Reprod Med. 1997 [cited 2020 Apr 16];42:76–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9058341.
Van Der Westerlaken LA, Naaktgeboren N, Helmerhorst FM. Evaluation of pregnancy rates after intrauterine insemination according to indication, age, and sperm parameters. J Assist Reprod Genet. 1998;15:359–64.
Sahakyan M, Harlow BL, Hornstein MD. Influence of age, diagnosis, and cycle number on pregnancy rates with gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril. 1999;72:500–4.
Corsan G, Trias A, Trout S, Kemmann E. Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile? Hum Reprod. Oxford University Press. 1996;11:1109–12.
Diamond MP, Legro RS, Coutifaris C, Alvero R, Robinson RD, Casson P, et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility. N Engl J Med. 2015;373(13):1230–40.
Evans MB, Stentz NC, Richter KS, Schexnayder B, Connell M, Healy MW, et al. Mature follicle count and multiple gestation risk based on patient age in intrauterine insemination cycles with ovarian stimulation. Obstet Gynecol. 2020;135(5):1005–14.
Van Voorhis BJ, Sparks AET, Allen BD, Stovall DW, Syrop CH, Chapler FK. Cost-effectiveness of infertility treatments: a cohort study. Fertil Steril. Elsevier Inc. 1997;67:830–6.
Goverde AJ, McDonnell J, Vermeiden JPW, Schats R, Rutten FFH, Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet Elsevier Limited. 2000;355:13–8.
Daar J, Benward J, Collins L, Davis J, Davis O, Francis L, et al. Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion. Fertil Steril. Elsevier Inc. 2019;111:659–63.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key messages
The use of intrauterine inseminations in women 43 years of age and older is an ineffective treatment strategy. This is irrespective of the use of ovarian stimulation or donor sperm.
Rights and permissions
About this article
Cite this article
Ruiter-Ligeti, J., Dahan, M.H., Steiner, N. et al. Is intrauterine insemination a viable treatment option for women over 43 years old? An analysis by ovarian stimulation protocol and sperm source. J Assist Reprod Genet 37, 3103–3107 (2020). https://doi.org/10.1007/s10815-020-01976-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-020-01976-3